³í¹®½ÇÀû

Áö¿ø°úÁ¦º° :
¿¬µµº° :
¸ðµÎº¸±â
Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry.(PRCDM)
Xenobiotica. 43(6):527-33 / 2013.06 [LINK]
2013-International
Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients.(PRCDM)
Int J Clin Pharmacol Ther. 51(5):383-92 / 2013.05 [LINK]
2013-International
Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects.(BMRC, PRCDM)
J Clin Pharmacol. 53(5):550-8 / 2013.05 [LINK]
2013-International
Identification and characterization of novel alternative splice variants of human constitutive androstane receptor in liver samples of Koreans and Caucasians.(PRCDM)
Drug Metab Dispos. 41(4):888-96 / 2013.04 [LINK]
2013-International
Effect of HNF4¥á genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals.(BMRC)
Pharmacogenet Genomics. 23(3):175-9 / 2013.03 [LINK]
2013-International
Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism.(BMRC, PRCDM)
Xenobiotica. 43(2)211-8 / 2013.02 [LINK]
2013-International
Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index.(PRCDM)
Br J Clin Pharmacol. 75(1):244-53 / 2013.01 [LINK]
2013-International
LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: Basal plasma concentrations and aspirin-induced changes of eicosanoids.(BMRC, PRCDM)
J Chromatogr B Analyt Technol Biomed Life Sci. 911:113-21 / 2012.12 [LINK]
2012-International
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.(BMRC)
Clin Nephrol. 78(5):412-8 / 2012.11 [LINK]
2012-International
Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities.(BMRC)
Drug Metab Pharmacokinet. 27(6):663-7 / 2012.12 [LINK]
2012-International